Centrus Energy HALEU Backlog Hits $3.9 Billion as Uranium Equities Retreat
A record forward book and a $900 million DOE contract position Centrus as a rare domestic nuclear fuel play, though much of its value hinges on unbuilt production capacity.
The URA uranium equity ETF fell 2.60% on Thursday (2026-09-24), continuing a broad retreat in nuclear equities even as the fundamentals underpinning Centrus Energy's order book kept building. Centrus, which operates the only U.S. commercial facility enriching uranium to high-assay low-enriched uranium specifications, reported a record $3.9 billion contracted backlog at the end of Q1 2026 (March 31, 2026) — a forward book stretching to 2040.3,5
Of that backlog, roughly $3.1 billion relates to the low-enriched uranium segment, with the remainder in technical services. Centrus reported $76.7 million in first-quarter revenue and $10 million in GAAP net income, while holding approximately $1.8 billion in cash, cash equivalents, and restricted cash — a cushion that puts it in a different financial category from most nascent nuclear fuel companies.3
The federal government is underwriting the enrichment business directly. The U.S. Department of Energy awarded Centrus a contract worth up to $900 million to establish a domestic HALEU supply chain, the fuel type required by advanced reactors and most small modular reactor designs. Washington has designated domestic nuclear fuel supply a matter of urgent national security, with the Russian uranium import ban scheduled to take effect in 2028 further concentrating attention on U.S.-origin supply.2,3
HALEU demand, for now, remains largely prospective. Oklo, whose shares trade on NYSE and which is developing fast fission reactors, has signed a letter of intent with Centrus for HALEU supply starting around 2029 — a letter of intent, not a firm purchase agreement. Oklo is not yet generating significant revenue. Most advanced reactor developers are still multiple years from commercial operation.4,5
The contrast with upstream miners illustrates where Centrus sits in the supply chain. Uranium Energy Corporation has mining and processing operations running and can sell yellowcake directly into uranium markets. It runs fully unhedged, giving it direct price exposure to any spot uranium move. Centrus, as an enricher operating under long-term contracts, is insulated from commodity price swings but also far less reactive to any uranium rally.4
That defined-risk profile attracted RPG Investment Advisory, which disclosed a new Centrus position via an SEC filing dated May 14, 2026 — 50,460 shares with a quarter-end value of $8.76 million as of March 31, 2026, representing 1.06% of the fund's 13F reportable assets. The fund's top three holdings remain Nvidia, Alphabet, and Apple. The Centrus stake reads as a considered thematic allocation, not a concentrated position.1
Centrus carries a market capitalisation of $3.64 billion against that $3.9 billion backlog. The ratio looks contained. But a meaningful portion of the backlog depends on Centrus securing additional public and private investment to build new LEU production capacity; without that capital, parts of the forward book are conditional rather than contractually firm.1,3
Utility demand supports the longer-term case. Operators are extending the lives of existing reactors, and large technology companies are exploring nuclear power to supply AI data centres, both trends pointing toward higher uranium and enrichment demand across this decade.3 Enrichment markets run on multi-year procurement cycles, though, and any slip in the DOE program timeline would push Centrus's production ramp further out.
Thursday's (2026-09-24) pullback in URA came against an otherwise firm commodity backdrop — ICE Brent crude front-month gained 2.00% to $107.96 per barrel in the same session. The divergence is familiar for uranium equities, which have historically repriced on news flow and sentiment faster than spot uranium itself adjusts. For Centrus specifically, the concrete signal to track is whether the DOE's HALEU program advances through its later phases under that $900 million contract, converting production intent into confirmed enrichment volumes.2